Reviewing the Key Lessons Learned from Phase 2 GA Trials

Time: 8:30 am
day: Day Two


  • Review of lessons learned from our IVT complement Factor P inhibitor GA Phase 2 trial
  • Data on how geographic atrophy is measured – the importance of patient level data vs summed data
  • Fundus autofluorescence measure vs OCT measurements – functional outcomes including chart-based tests vs microperimetry